ProCE Banner Activity

My Thoughts on the Implications of Key New Data in B-Cell Malignancies From ASCO and EHA 2020

Clinical Thought
Are you aware of the latest practice changing new data related to the care of patients with B-cell malignancies from ASCO and EHA 2020?

Released: July 16, 2020

Expiration: July 15, 2021

Share

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Lydia Scarfò, MD

Assistant Professor
Internal Medicine
Università Vita-Salute San Raffaele
Consultant Hematologist
Strategic Research Program on CLL
Milan, Italy

Lydia Scarfò, MD, has disclosed that she has received consulting fees from AbbVie, AstraZeneca, Gilead Sciences, and Janssen.